Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States.

Zhai, Yinghong; Ye, Xiaofei; Hu, Fangyuan; Xu, Jinfang; Guo, Xiaojing; Cao, Yang; Lin, Zhen; Zhou, Xiang; Guo, Zhijian; He, Jia.

Zhai Y; School of Medicine, Tongji University, Shanghai, China.
Ye X; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Hu F; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Xu J; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Guo X; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Cao Y; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Lin Z; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Zhou X; Department of Health Statistics, Second Military Medical University, Shanghai, China.
Guo Z; School of Medicine, Tongji University, Shanghai, China.
He J; Department of Health Statistics, Second Military Medical University, Shanghai, China.